Skip to search boxSkip to navigationSkip to main content

Linkage to peroxisome proliferator-activated receptor-γ in SAMP1/YitFc mice and in human Crohn's disease

  • Kazuhiko Sugawara
    ,
  • Timothy S. Olson
    ,
  • Christopher A. Moskaluk
    ,
  • Brian K. Stevens
    ,
  • Sharon Hoang
    ,
  • Kosuke Kozaiwa
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Background & Aims: Genetic predisposition is implicated strongly in Crohn's disease. Disease-associated mutations in NOD2/CARD15, the best-studied susceptibility gene in this disorder, explain only a small fraction of the heritability. The SAMP1/YitFc (SAMP1/Fc) mouse strain expresses many features of Crohn's disease in humans. We bred SAMP1/Fc to disease-resistant AKR mice to identify additional susceptibility genes that may play a role in human disease. Methods: Linkage disequilibrium mapping was performed in an (AKR × SAMP1/Fc) backcross to SAMP1/Fc, followed by sequencing, expression analysis using reverse transcription polymerase chain reaction (PCR) and immunohistochemistry, and functional testing in vivo of the regional candidate gene encoding the peroxisome proliferator-activated receptor γ (Pparg). A cohort-based association study was performed in humans. Results: We show that ileitis is blocked in SAMP1/Fc mice by inheritance of AKR alleles on chromosome 6 in the region of Pparg. Major differences in Pparγ expression in the parental mouse strains are found specifically in the crypts of the small intestine, and treatment of ileitis-prone mice with a Pparγ agonist decreased disease severity in susceptible mice expressing low levels of the protein. Rare alleles of PPARG are associated significantly with Crohn's disease in humans. Conclusions: We have identified Pparg as a susceptibility gene in both the SAMP/Yit mouse and in human Crohn's disease. Similarities between Crohn's disease and the SAMP1/Fc model suggest that the effect of this gene in humans may be mediated through regulation of PPARγ activity in the crypts of the small intestine.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 351-360 (10 pages)

Journal (Volume, Issue Number)

Gastroenterology (Volume 128, Issue 2)

Publication milestones

  • Published - 02/2005

Publication status

Published - 02/2005

ISSN

0016-5085

Publication IDs

  • Scopus: 14944361781
  • PubMed: 15685547

Publication metrics

Metrics

Fractional count
1
Fractional count
0.11
Fractional count
8
Fractional count
0.89
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Citation count
82
Captures
60

Funding Details

Supported by the National Institute of Digestive, Diabetes, and Kidney Diseases (PO1 DK57880), the Crohn’s and Colitis Foundation (to K.S.), and the Uehara Memorial Foundation (to K.K.).
FundersFunding numbers
National Institute of Diabetes and Digestive
PO1 DK57880
NIDDK
P01DK057880
Uehara Memorial Foundation
-
Crohn's and Colitis Foundation
-